| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 08/12/2004 | US20040157828 Protease inhibitors |
| 08/12/2004 | US20040157818 antagonism to chemokine receptor CXCR4 for treatment of rheumatism or cancer metastasis |
| 08/12/2004 | US20040157796 Concentrated liquid valdecoxib composition |
| 08/12/2004 | US20040157788 production of antibodies containing K light chains, in order to provide high affinity reproducibly |
| 08/12/2004 | US20040157783 co-administration of a glutathione precursor (N-acetyl cysteine or alpha -lipoic acid) and hydroxocobalamin (a derivative of Vitamin B12) to patients with a functional Vitamin B12 deficiency and suffering from a neuropsychiatric abnormality |
| 08/12/2004 | US20040157778 computer program, which can be used for obtaining optimized dosage regimens for a desired pharmacodynamic response |
| 08/12/2004 | US20040157772 Use of a gatran for the manufacture of a medicament of the treatment of pulmonary fibrosis |
| 08/12/2004 | US20040157282 Regulation of human dual specificity protein phosphatase 7-like protein |
| 08/12/2004 | US20040157073 Lubricious coatings for substrates |
| 08/12/2004 | US20040156900 core of an active agent and a swelling agent, and a coating of film forming polymer, which swells when it imbibes fluid from the core and ruptures to release the drug in a pulse in a reliable manner |
| 08/12/2004 | US20040156887 Stabilized dispersion of phytosterol in oil |
| 08/12/2004 | US20040156838 inducing cytotoxic T-lymphocytes that will specifically down-regulate B-cells producing autologous IgE, notably by means of nucleic acid vaccination or live vaccination; inducing a combined antibody and CTK response specific for IgE |
| 08/12/2004 | US20040156791 Heating antipsychotic drug to vaporize; cooling to form condensation aerosol; kit for dispensing thin coating |
| 08/12/2004 | US20040156790 Delivery of drug esters through an inhalation route |
| 08/12/2004 | US20040156789 Delivery of antihistamines through an inhalation route |
| 08/12/2004 | US20040156788 Delivery of erectile dysfunction drugs through an inhalation route |
| 08/12/2004 | CA2514575A1 Crystal of (23s)-1.alpha.-hydroxy-27-nor-25-methylenevitamin d3-26,23-lactone and process for producing the same |
| 08/12/2004 | CA2514547A1 Receptor agonists |
| 08/12/2004 | CA2514125A1 Composition for and treatment of demyelinating diseases and paralysis by administration of remyelinating agents |
| 08/12/2004 | CA2514117A1 Composition for and treatment of demyelinating diseases and paralysis by administration of remyelinating agents |
| 08/12/2004 | CA2512988A1 Dispersion of taste masked crystals or granules of active substances, chewable soft capsules filled with said dispersion, and process for preparing same |
| 08/11/2004 | EP1445258A1 Activator for peroxisome proliferator-activated receptor delta |
| 08/11/2004 | EP1445250A1 Novel amine derivative having human beta-tryptase inhibitory activity and drugs containing the same |
| 08/11/2004 | EP1445249A1 Novel bensophenone derivatives or salts thereof |
| 08/11/2004 | EP1444984A1 Topical pharmaceutical compositions containing natural active constituents suitable for the prevention and treatment of mucosal inflammation processes |
| 08/11/2004 | EP1444330A1 Expansion of t cells in vitro and expanded t cell populations |
| 08/11/2004 | EP1444267A2 Affinity enhancement agents |
| 08/11/2004 | EP1444254A2 Molecules for disease detection and treatment |
| 08/11/2004 | EP1444251A1 Cyclic peptides as g-protein-coupled receptor antagonists |
| 08/11/2004 | EP1444248A2 Novel anti-inflammatory androstane derivatives - 17-carboxy-lactone substituted steroids with an aryl-carboxylic ester in position 17.alpha |
| 08/11/2004 | EP1444235A1 Reverse-turn mimetics and method relating thereto |
| 08/11/2004 | EP1444226A1 Compounds useful as reversible inhibitors of cysteine proteases |
| 08/11/2004 | EP1444223A1 Aminopyrimidines and -pyridines |
| 08/11/2004 | EP1444212A1 Substituted (1h)-quinoxalin-2-one compounds and substituted 4-aryl- and 4-heteroarylcyclohexane compounds |
| 08/11/2004 | EP1444209A2 Mitotic kinesin inhibitors |
| 08/11/2004 | EP1444207A2 Substituted pyrazolyl-compounds for the treatment of inflammation |
| 08/11/2004 | EP1444206A1 Substituted benzo b azepin-2-one compounds |
| 08/11/2004 | EP1444203A1 Cannabinoid receptor ligands |
| 08/11/2004 | EP1444202A1 Novel metalloproteinase inhibitors |
| 08/11/2004 | EP1444201A1 2-(3-sulfonylamino-2-oxopyrrolidin-1-yl)propanamides as factor xa inhibitors |
| 08/11/2004 | EP1444010A2 Heteroaromatic carboxamide derivatives for the treatment of inflammation |
| 08/11/2004 | EP1443965A1 Treatment of inflammatory conditions |
| 08/11/2004 | EP1443961A2 Glycoprotein compositions |
| 08/11/2004 | EP1443944A1 Pharmaceutical applications of hyaluronic acid preparations |
| 08/11/2004 | EP1443943A1 Process for reacting alkaloids and use of the reaction products in the preparation of medicaments |
| 08/11/2004 | EP1443942A1 Pharmaceutical composition for use for the treatment of malignancies comprising in combination a bisphosphonates, a cox-2 inhibitor and a taxol |
| 08/11/2004 | EP1443937A1 Substituted 1,4-benzodiazepines and uses thereof for the treatment of cancer |
| 08/11/2004 | EP1443935A2 Treatment of infectious disease using interleukin-1 beta converting enzyme (ice)/ced-3 family inhibitors |
| 08/11/2004 | EP1443925A1 Naphthyridine derivatives, their preparation and their use as phosphodiesterase isoenzyme 4 (pde4) inhibitors |
| 08/11/2004 | EP1443915A1 Pharmaceutical and cosmetic compositions containing oxy group-bearing aromatic aldehydes |
| 08/11/2004 | EP1443906A1 Method for the formation of ibuprofen crystals |
| 08/11/2004 | EP1363677A4 Method of using a variant of vegf receptor to treat psoriasis and to enhance wound healing |
| 08/11/2004 | EP1358182B1 Diazocine derivatives and their use as tryptase inhibitors |
| 08/11/2004 | EP1155003B1 Novel guanidine derivatives as inhibitors of cell adhesion |
| 08/11/2004 | EP1154988B1 Mevinolin derivatives |
| 08/11/2004 | EP1147095B1 2, 3, 4, 5-tetrahydro-1h-[1, 4] benzodiazepine-3-hydroxamic acids as matrix metalloproteinase inhibitors |
| 08/11/2004 | EP1135164B1 Composition for the treatment of inflammation |
| 08/11/2004 | EP1107965B1 Pyridyl ethers and thioethers as ligands for nicotinic acetylcholine receptor and its therapeutic application |
| 08/11/2004 | EP1056714B1 Phenylalanine derivatives as inhibitors of alpha4 integrins |
| 08/11/2004 | EP1012142B1 2,3,5-trisubstituted pyridines as inhibitors of cyclooxygenase-2 |
| 08/11/2004 | EP0977859B1 The neurotrophic factor nnt-1 |
| 08/11/2004 | EP0852491B1 Use of heparinases to decrease inflammatory responses |
| 08/11/2004 | CN1520424A Immunoglobulins 2 |
| 08/11/2004 | CN1520416A 碳水化合物衍生物 Carbohydrate derivatives |
| 08/11/2004 | CN1520409A Piperazine oxime derivatives having Nk-1 receptor antagonistic activity |
| 08/11/2004 | CN1520408A Piperazine compounds |
| 08/11/2004 | CN1520402A Unsymmetrical cyclic diamine compound |
| 08/11/2004 | CN1520401A Calcilytic compounds |
| 08/11/2004 | CN1520400A Cyclic diamine compounds bearing six-membered cyclic groups |
| 08/11/2004 | CN1520395A Cycloalkenone derivative |
| 08/11/2004 | CN1520309A Methods and compsns. for treating oral and eosophagal lesions |
| 08/11/2004 | CN1520300A Dihydro-triterpenes in treatment of viral infections, cardiovascular disease, inflammation, hypersensitivity or pain |
| 08/11/2004 | CN1520298A Pyrazolopyrimidines as therapeutic agents |
| 08/11/2004 | CN1520297A Sustained release drug delivery system contg. codrugs |
| 08/11/2004 | CN1520293A 3-flworo-pyrrolidines as antidiabetic agents |
| 08/11/2004 | CN1520292A Medicinal compsns. |
| 08/11/2004 | CN1520290A Carbocyclic hydrorazino inhibitors of copper-containing amine oxidases |
| 08/11/2004 | CN1520283A Control of compactability through crystallization |
| 08/11/2004 | CN1520281A Compsn. for treatment of burns |
| 08/11/2004 | CN1519246A Salt of organic acid of cyclorrirobuxin-D, pharmaceutics and application as well as its preparation method |
| 08/11/2004 | CN1519240A Substituted nitrogen contg. heterocycles as inhibitors of P38 progein kinase |
| 08/11/2004 | CN1519030A Biologica preparation modified in plasma environment for treating rheumatalgia and preparation method |
| 08/11/2004 | CN1519014A Multifunctional ointment for promoting blood flow and composedness as well as preparation method |
| 08/11/2004 | CN1519007A Prepared Chinese medicine for treating yang disease of boil caused by accumulated noxious heat |
| 08/11/2004 | CN1519000A Medicinal liquor for treating arthralgia |
| 08/11/2004 | CN1518997A Penetrant for fast treating rheumatoid arthritis and preparation method |
| 08/11/2004 | CN1518994A Prescription of Chinese traditional medicine for relieving inflammation, detoxification and cancer prevention |
| 08/11/2004 | CN1518992A Application of 'Qingkailing' in preparing medication for treating diseases in nerve and immunity |
| 08/11/2004 | CN1518982A Active component of muskrat fragrant, preparing technique and usage |
| 08/11/2004 | CN1161379C Novel peptides derived from autoantigent for use in immunitherapy of autoimmune diseases |
| 08/11/2004 | CN1161355C New compounds |
| 08/11/2004 | CN1161352C Quinazoline derivatives |
| 08/11/2004 | CN1161339C Pyrazoles derivs., Pharmaceutical salt thereof and composition contg. same |
| 08/11/2004 | CN1161338C Fluorinated 3,4-dihydroquinoline derivatives used and NOS inhibitors |
| 08/11/2004 | CN1161331C Hydrazine derivatives |
| 08/11/2004 | CN1161152C Method and composition useful for inhibition of angiogenesis |
| 08/11/2004 | CN1161147C Oral Chinese medicine for curing osteoarthropathy |
| 08/11/2004 | CN1161121C Alkaloid of matrine category utilized for mainline and its preparation method |
| 08/11/2004 | CN1161119C Lefunomide plaster and its prepn. method |
| 08/11/2004 | CN1161118C Use of 5HT3 receptor antagouists for the treatment of chronic fatigue syndrome |